Ameliorating effects of sphingomyelin-based liposomes on sarcopenia in senescence-accelerated mice

Biological and Pharmaceutical Bulletin

Volumn 39, Issue 5, 2016, Pages 786-793

  Ishida, Yuuki ^a   Kiyokawa, Yuri ^a   Asai, Tomohiro ^a   Oku, Naoto ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Liposome; Muscle; Sarcopenia; Senescence accelerated mouse; Sphingomyelin

Indexed keywords

LIPOSOME; SPHINGOMYELIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACO 2 CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG MECHANISM; DRUG TRANSPORT; FATIGUE; HYDRATION; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; INTESTINE FLUID; MALE; MOUSE; MUSCLE FUNCTION; MUSCLE MASS; MYOBLAST; NONHUMAN; QUADRICEPS FEMORIS MUSCLE; SARCOPENIA; SENESCENCE; STOMACH SECRETION; TRANSMISSION ELECTRON MICROSCOPY; AGING; ANIMAL; CACO-2 CELL LINE; CELL LINE; CYTOLOGY; DRUG EFFECTS; HUMAN; MUSCLE WEAKNESS;

AGING; ANIMALS; CACO-2 CELLS; CELL LINE; CELL PROLIFERATION; HUMANS; LIPOSOMES; MALE; MICE; MUSCLE WEAKNESS; MYOBLASTS; SARCOPENIA; SPHINGOMYELINS;

EID: 84968649829     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b15-00915     Document Type: Article

References (54)

1. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The health care costs of sacopenia in the United States. J. Am. Geriatr. Soc., 52, 80-85 (2004).
2. Sinha-Hikim I, Sinha-Hikim AP, Parveen M, Shen R, Goswami R, Tran P, Crum A, Norris KC. Long-term supplementation with a cystine-based antioxidant delays loss of muscle mass in aging. J. Gerontol. A Biol. Sci. Med. Sci., 68, 749-759 (2013).
3. Tan LJ, Liu SL, Lei SF, Papasian CJ, Deng HW. Molecular genetic studies of gene identification for sarcopenia. Hum. Genet., 131, 1-31 (2012).
4. Vincent G, Lamon S, Gant N, Vincent PJ, MacDonald JR, Markworth JF, Edge JA, Hickey AJ. Changes in mitochondrial function and mitochondria associated protein expression in response to 2-weeks of high intensity interval training. Front. Physiol., 6, 51 (2015).
5. Casperson SL, Sheffield-Moore M, Hewlings SJ, Paddon-Jones D. Leucine supplementation chronically improves muscle protein synthesis in older adults consuming the RDA for protein. Clin. Nutr., 31, 512-519 (2012).
6. Deldicque L, Louis M, Theisen D, Nielens H., Denhoux M, Thissen J-P, Rennie MJ, Francaux M. Increased IGF mRNA in human skeletal muscle after creatine supplementation. Med. Sci. Sports Exerc., 37, 731-736 (2005).
7. Katsanos CS, Chinkes DL, Paddon-Jones D, Zhang XJ, Aarsland A, Wolfe RR. Whey protein ingestion in elderly persons results in greater muscle protein accrual than ingestion of its constituent essential amino acid content. Nutr. Res., 28, 651-658 (2008).
8. Thudichum JLW. A treatise on the chemical constitution of brain. Bailliere, Tindall, and Cox, London, U.K. (1884).
9. Vesper H, Schmelz EM, Nikolova-Karakashian MN, Dillehay DL, Lynch DV, Merrill AH Jr. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J. Nutr., 129, 1239-1250 (1999).
10. Zeisel SH, Char D, Sheard NF. Choline, phosphatidylcholine and sphingomyelin in human and bovine milk and infant formulas. J. Nutr., 116, 50-58 (1986).
11. Zeisel SH, Mar MH, Howe JC, Holden JM. Concentrations of choline-containing compounds and betaine in common foods. J. Nutr., 133, 1302-1307 (2003).
12. Morita SY, Kawabe M, Sakurai A, Okuhira K, Vertut-Doï A, Nakano M, Handa T. Ceramide in lipid particles enhances heparin sulfate proteoglycan and low density lipoprotein receptor-related protein-mediated uptake by macrophages. J. Biol. Chem., 279, 24355-24361 (2004).
13. Holland WL, Summers SA. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr. Rev., 29, 381-402 (2008).
14. Hla T, Dannenberg AJ. Sphingolipid signaling in metabolic disorders. Cell Metab., 16, 420-434 (2012).
15. Haramizu S, Ota N, Otsuka A, Hashizume K, Sugita S, Hase T, Murase T, Shimotoyodome A. Dietary milk fat globule membrane improves endurance capacity in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol., 307, R1009-R1017 (2014).
16. Sabbadini RA, Danieli-Betto D, Betto R. The role of sphingolipids in the control of skeletal muscle function: a review. Ital. J. Neurol. Sci., 20, 423-430 (1999).
17. Nagata Y, Partridge TA, Matsuda R, Zammit PS. Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling. J. Cell Biol., 174, 245-253 (2006).
18. Rosenfeldt HM, Amrani Y, Watterson KR, Murthy KS, Panettieri RA Jr, Spiegel S. Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells. FASEB J., 17, 1789-1799 (2003).
19. Danieli-Betto D, Germinario E, Esposito A, Megighian A, Midrio M, Ravara B, Damiani E, Libera LD, Sabbadini RA, Betto R. Sphingosine 1-phosphate protects mouse extensor digitorum longus skeletal muscle during fatigue. Am. J. Physiol. Cell Physiol., 288, C1367-C1373 (2005).
20. Nilsson A, Duan RD. Absorption and lipoprotein transport of sphingomyelin. J. Lipid Res., 47, 154-171 (2006).
21. Nyberg L, Nilsson A, Lundgren P, Duan RD. Localization and capacity of sphingomyelin digestion in the rat intestinal tract. J. Nutr. Biochem., 8, 112-l18 (1997).
22. Nilsson A. Metabolism of sphingomyelin in the intestinal tract of the rat. Biochim. Biophys. Acta, 164, 575-584 (1968).
23. Iwanaga K, Ono S, Narioka K, Kakemi M, Morimoto K, Yamashita S, Namba Y, Oku N. Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin. J. Pharm. Sci., 88, 248-252 (1999).
24. Thongborisute J, Takeuchi H, Yamamoto H, Kawashima Y. Visualization of the penetrative and mucoadhesive properties of chitosan and chitosan-coated liposomes through the rat intestine. J. Liposome Res., 16, 127-141 (2006).
25. Sugihara H, Yamamoto H, Kawashima Y, Takeuchi H. Effectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacin. J. Liposome Res., 22, 72-79 (2012).
26. Malmsten M, Bergenståhl B, Nyberg L, Odham G. Sphingomyelin from milk-characterization of liquid crystalline, liposome and emulsion properties. J. Am. Oil Chem. Soc., 71, 1021-1026 (1994).
27. Tokudome Y, Uchida R, Yokote T, Todo H, Hada N, Kon T, Yasuda J, Hayashi H, Hashimoto F, Sugibayashi K. Effect of topically applied sphingomyelin-based liposomes on the ceramide level in a three-dimensional cultured human skin model. J. Liposome Res., 20, 49-54 (2010).
28. Kisel MA, Kulik LN, Tsybovsky IS, Vlasov AP, Vorob'yov MS, Kholodova EA, Zabarovskaya ZV. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. Int. J. Pharm., 216, 105-114 (2001).
29. Pinto M. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell, 47, 323-330 (1983).
30. Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736-749 (1989).
31. Rodríguez-Alcalá LM, Fontecha J. Major lipid classes separation of buttermilk, and cows, goats and ewes milk by high performance liquid chromatography with an evaporative light scattering detector focused on the phospholipid fraction. J. Chromatogr. A, 1217, 3063-3066 (2010).
32. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol., 147, 755-763 (1998).
33. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 39, 412-423 (2010).
34. Walrand S, Guillet C, Salles J, Cano N, Boirie Y. Physiopathological mechanism of sarcopenia. Clin. Geriatr. Med., 27, 365-385 (2011).
35. Koopman R, van Loon LJ. Aging, exercise and muscle protein metabolism. J. Appl. Physiol., 106, 2040-2048 (2009).
36. Rolland Y, Czerwinski S, Abellan Van Kan G, Morley JE, Cesari M, Onder G, Woo J, Baumgartner R, Pillard F, Boirie Y, Chumlea WM, Vellas B. Sacropenia: it's assessment, etiology, pathogenesis, consequences and future perspectives. J. Nutr. Health Aging, 12, 433-450 (2008).
37. Yarasheski KE. Exercise, aging and muscle protein metabolism. J. Gerontol. A Biol. Sci. Med. Sci., 58, M918-M922 (2003).
38. Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr. Opin. Clin. Nutr. Metab. Care, 12, 86-90 (2009).
39. Sabbadini RA, Danieli-Betto D, Betto R. The role of sphingolipids in the control of skeletal muscle function. Ital. J. Neurol. Sci., 20, 423-430 (1999).
40. Danieli-Betto D, Germinario E, Esposito A, Megighian A, Midrio M, Ravara B, Damiani E, Libera LD, Sabbadini RA, Betto R. Sphingosine 1-phosphate protects mouse extensor digitorum longus skeletal muscle during fatigue. Am. J. Physiol. Cell Physiol., 288, C1367-C1373 (2005).
41. Artursson P. Cell cultures as models for drug absorption across the intestinal mucosa. Crit. Rev. Ther. Drug Carrier Syst., 8, 305-330 (1991).
42. Hovgaard L, Brondsted H, Nielsen HM. Drug delivery studies in caco-2 monolayer. II. absorption enhancer effects of lysophosphatidylcholines. Int. J. Pharm., 114, 141-149 (1995).
43. Johansson F, Hjertberg E, Eirefelt S, Tronde A, Hultkvist Bengtsson U. Mechanism for absorption enhancement of inhaled insulin by sodium taurocholate. Eur. J. Pharm. Sci., 17, 63-71 (2002).
44. Kansy M, Senner F, Gubernator K. Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes. J. Med. Chem., 41, 1007-1010 (1998).
45. Kerns EH, Di L, Petusky S, Farris M, Ley R, Jupp P. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery. J. Pharm. Sci., 93, 1440-1453 (2004).
46. Moran JL, Li Y, Hill AA, Mounts WM, Miller CP. Gene expression changes during mouse skeletal myoblast differentiation revealed by transcriptional profiling. Physiol. Genomics, 10, 103-111 (2002).
47. Delgado I, Huang X, Jones S, Zhang L, Hatcher R, Gao B, Zhang P. Dynamic gene expression during the onset of myoblast differentiation in vitro. Genomics, 82, 109-121 (2003).
48. Tomczak KK, Marinescu VD, Ramoni MF, Sanoudou D, Montanaro F, Han M, Kunkel LM, Kohane IS, Beggs AH. Expression profiling and identification of novel genes involved in myogenic differentiation. FASEB J., 18, 403-405 (2004).
49. Haramizu S, Mori T, Yano M, Ota N, Hashizume K, Otsuka A, Hase T, Shimotoyodome A. Habitual exercise plus dietary supplementation with milk fat globule membrane improves muscle function deficits via neuromuscular development in senescence-accelerated mice. SpringerPlus, 3, 339 (2014).
50. Diel P, Baadners D, Schlüpmann K, Velders M, Schwarz JP. C2C12 myoblastoma cell differentiation and proliferation is stimulated by androgens and associated with a modulation of myostatin and Pax7 expression. J. Mol. Endocrinol., 40, 231-241 (2008).
51. Carlson CJ, Booth FW, Gordon SE. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am. J. Physiol., 277, R601-R606 (1999).
52. Verdijk LB, Gleeson BG, Jonkers RA, Meijer K, Savelberg HH, Dendale P, van Loon LJ. Skeletal muscle hypertrophy following resistance training is accompanied by a fiber type-specific increase in satellite cell content in elderly men. J. Gerontol. A Biol. Sci. Med. Sci., 64A, 332-339 (2009).
53. Bernacchioni C, Cencetti F, Blescia S, Donati C, Bruni P. Sphingosine kinase/sphingosine 1-phosphate axis: a new player for insulin-like growth factor-1-induced myoblast differentiation. Skelet. Muscle, 2, 15 (2012).
54. Jäger R, Purpura M, Kingsley M. Phospholipids and sports performance. J. Int. Soc. Sports Nutr., 4, 5 (2007).